4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Nautilus Biotechnology, Inc. (NAUT) operates in the Biotechnology industry and is headquartered in Seattle, United States with about 127 employees. Its market capitalization is roughly $215 million. In the fiscal year ended 2025-12-31, NAUT reported $0M in revenue and ($59M) in net income.
Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome in the United States.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M |
| Operating Income (EBIT) | ($67M) | ($82M) | ($76M) | ($64M) |
| Net Income | ($59M) | ($71M) | ($64M) | ($58M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($16M) | ($15M) | ($16M) | ($17M) | ($19M) | — |
| Net Income | ($15M) | ($14M) | ($14M) | ($15M) | ($17M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $191M | $243M | $306M | $350M | — |
| Total Liabilities | $34M | $34M | $40M | $35M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive NAUT viewer.
About TickerBase · Data methodology & sources